Creating a central source of truth for next-generation sequencing

Arbor Biotech has a unique approach to gene editing that puts them at the forefront of developing future genomic medicines: it all starts with their programmable DNA editors. They’ve developed an extensive toolbox of proprietary genomic editors in the industry, which allows them to work backwards to create genetic medicines — starting from the disease pathology and selecting the optimal editor or set of editors.

Seeking a centralized data foundation for NGS and beyond

Arbor saw the opportunity to improve their pace of discovery in several areas: implementing structured and consistent data submission, introducing more efficient management of next-generation sequencing (NGS) processes, and enhancing traceability. To take action, they started a free plan of Benchling as a central source of truth for their research data. Shortly after, they saw immediate benefits of Benchling — and they upgraded to bring more teams onto the platform.  

Improving research processes through a central source of truth for data

With Benchling, Arbor achieved a paradigm shift in data management, fostering unity across teams by standardizing procedures and automating workflows. This coherence streamlined data capture, while the integration of mandatory fields facilitated a more agile and efficient approach to research.

Benchling's impact also extended beyond data management and played a part in revolutionizing Arbor’s NGS processes. Smoother collaboration led to increased throughput, better resource utilization, and the ability for researchers to navigate complex datasets with ease. Rapid identification and resolution of errors and improved traceability led to expedited troubleshooting processes, which accelerates the pace of Arbor’s research.